Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21147555 | 0.95 | MAPT (0.31) | — | |
| SCHEMBL21147174 | 0.92 | PLA2G2A (0.32) | PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL18868053 | 0.91 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10PRKDCPGR | |
| SCHEMBL23339760 | 0.90 | HCRTR1 (0.33) | PLA2G2APLA2G4APLA2G10PRKDCPGR | |
| SCHEMBL21147010 | 0.89 | PLA2G2A (0.35) | PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL23339754 | 0.88 | HCRTR1 (0.33) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL24390343 | 0.88 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10PRKDCHPSE | |
| SCHEMBL25800111 | 0.88 | MAPK14 (0.31) | — | |
| SCHEMBL24604069 | 0.88 | KDM4E (0.34) | — | |
| SCHEMBL25799802 | 0.88 | KDM4E (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-20200212314-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
| US-20190214570-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CRY1, CYP1B1, CYP1A1 | PLA2G2A 4266/4885PLA2G4A 4371/4885PLA2G10 4214/4885 |
| US-20190214570-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | CRY1, CYP1B1, CYP1A1 | PLA2G2A 4266/4885PLA2G4A 4371/4885PLA2G10 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.